J. Nelson

Strategies for the discovery of novel tyrosine kinase inhibitors with anticancer activity.

David W. Fry, A. J. Kraker, R. C. Connors et al. · PubMed · 1994 · 32 citations

Medicine, Oncology, Pharmacology +13

Growth inhibition of nasopharyngeal carcinoma cells by EGF receptor tyrosine kinase inhibitors.

Yihua Sun, David W. Fry, P. Vincent et al. · PubMed · 1999 · 18 citations

Medicine, Oncology, Pharmacology +16

Cell cycle effects of trimetrexate (CI-898)

KennethE. Hook, J. Nelson, BillyJ. Roberts et al. · Cancer Chemotherapy and Pharmacology · 1986 · 17 citations

Life Sciences, Cell Biology, Pharmacology +12

Inhibition of epidermal growth factor receptor tyrosine kinase fails to suppress adenoma formation in ApcMin mice but induces duodenal injury.

Steven R. Ritland, Sandra Gendler, L J Burgart et al. · PubMed · 2000 · 16 citations

Medicine, Oncology, Pharmacology +16

1,1'-Bis(trimethylsilyl)ferrocenium Tetrachloroaluminate(1–), 1,1'-Bis(trimethylsilyl)ferrocene and 1,1'-Dimethylferrocene

Daniel A. Foucher, Charles H. Honeyman, Alan J. Lough et al. · Acta Crystallographica Section C Crystal Structure Communications · 1995 · 14 citations

Natural Sciences, Chemistry, Crystal Structure +5